However, previous findings on the prognostic value of BRCA1 for NSCLC have been inconsistent or conflicting, which may be attributed to the small number of patients from a single center or disparity in the ratio of patients with lung adenocarcinoma (LUAD) versus squamous cell carcinoma (LUSC) [5]. The gene discussed is BRCA1; the disease is lung adenocarcinoma.